Dr. Howard Hochester is a Distinguished Professor of Medicine at the Rutgers Robert Wood Johnson Medical School. He is the Associate Director for Clinical Research and Director of GI Oncology at Rutgers Research Institute and Director of Oncology Research at RWJBarnabas Health.
Dr. Hochster’s clinical expertise and research interests are dedicated to early drug development and clinical pharmacology, focused on tumors of the gastrointestinal tract. He has led numerous clinical trials and has been at the forefront of clinical research in Gastrointestinal Oncology. Dr. Hochster has been instrumental in the approval of eight new drugs for the treatment of colon cancer. He has authored more than 150 peer-reviewed articles on cancer therapy, new drug development, and clinical trials and has presented many of these study results at national meetings. Dr. Hochster is very involved with the NCI National Clinical Trials Network (NCTN) and have chaired ten phase 2 and phase 3 studies in the NCI cooperative groups. In addition, Dr. Hochester is an Associate Director for the Journal of the National Cancer Institute and Journal of GI Oncology.
Dr. Hochester is a graduate from the Yale School of Medicine and completed his residency, and fellowship in Hematology-Oncology at Bellevue Hospital and NYU Medical Center.